Monday, May 11, 2009

Phase III Clinical Trials

Psych Central recently wrote a post about why Phase III trials may often be misleading. At this stage, the clinical trial has to prove that the drug is both safe and effective. However, the article points out that oftentimes, Phase III trials are conducted on patients that may not be the consumers of the product in normal circumstances. Read the full article here. What do you think? If clinical trials are conducted on those who are not the preferred profile for the drug, will the results still be completely reliable?

No comments:

Post a Comment